Skip to content

Insider · CIK 0001079462

Stephen A Sherwin

director

Files at BIIB (BIOGEN INC.), NBIX (NEUROCRINE BIOSCIENCES INC). First filing Mar 10, 2025, latest Mar 10, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $1.3M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

BIIB: BIOGEN INC.

BIIBOct 9, 2026 · close 225.71

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
30Weak
BIIBsell10b5-1
BIOGEN INC.
$1.3M
8,760 shares
-44%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 2, 2026NBIX
NEUROCRINE BIOSCIENCES INC
GGift
Common Stock
-1,000$0.00$014,86039 d ago
Jun 17, 2025BIIB
BIOGEN INC.
AGrant or award
Common Stock
+2,370$0.00$013,688Jun 18, 2025
May 22, 2025NBIX
NEUROCRINE BIOSCIENCES INC
MOption exercise
Common Stock
+2,869$0.00$013,542May 22, 2025
May 21, 2025NBIX
NEUROCRINE BIOSCIENCES INC
AGrant or award
Restricted Stock Unitderivative
+3,318$0.00$03,318May 22, 2025
May 22, 2025NBIX
NEUROCRINE BIOSCIENCES INC
MOption exercise
Restricted Stock Unitderivative
-2,869$0.00$00May 22, 2025
Mar 7, 2025BIIB
BIOGEN INC.
SOpen-market sale
Common Stock10b5-1
-8,760$150.02$1.3M11,318Mar 10, 2025
Nov 4, 2024NBIX
NEUROCRINE BIOSCIENCES INC
GGift
Common Stock
-2,000$0.00$024,504Nov 7, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Stephen A Sherwin: insider trades and track record | InsiderTell